Premium
Performance of third‐trimester combined screening model for prediction of adverse perinatal outcome
Author(s) -
Miranda J.,
Triunfo S.,
RodriguezLopez M.,
Sairanen M.,
Kouru H.,
ParraSaavedra M.,
Crovetto F.,
Figueras F.,
Crispi F.,
Gratacós E.
Publication year - 2017
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.17317
Subject(s) - medicine , umbilical artery , small for gestational age , obstetrics , population , fetal distress , gestational age , gestation , apgar score , birth weight , estriol , prospective cohort study , pregnancy , fetus , genetics , estrogen , environmental health , biology
Objective To explore the potential value of third‐trimester combined screening for the prediction of adverse perinatal outcome (APO) in the general population and among small‐for‐gestational‐age (SGA) fetuses. Methods This was a nested case–control study within a prospective cohort of 1590 singleton gestations undergoing third‐trimester evaluation (32 + 0 to 36 + 6 weeks' gestation). Maternal baseline characteristics, mean arterial blood pressure, fetoplacental ultrasound and circulating biochemical markers (placental growth factor (PlGF), lipocalin‐2, unconjugated estriol and inhibin A) were assessed in all women who subsequently had an APO ( n = 148) and in a control group without perinatal complications ( n = 902). APO was defined as the occurrence of stillbirth, umbilical artery cord blood pH < 7.15, 5‐min Apgar score < 7 or emergency operative delivery for fetal distress. Logistic regression models were developed for the prediction of APO in the general population and among SGA cases (defined as customized birth weight < 10 th centile). Results The prevalence of APO was 9.3% in the general population and 27.4% among SGA cases. In the general population, a combined screening model including a‐priori risk (maternal characteristics), estimated fetal weight (EFW) centile, umbilical artery pulsatility index (UA‐PI), estriol and PlGF achieved a detection rate for APO of 26% (area under receiver–operating characteristics curve (AUC), 0.59 (95% CI, 0.54–0.65)), at a 10% false‐positive rate (FPR). Among SGA cases, a model including a‐priori risk, EFW centile, UA‐PI, cerebroplacental ratio, estriol and PlGF predicted 62% of APO (AUC, 0.86 (95% CI, 0.80–0.92)) at a FPR of 10%. Conclusions The use of fetal ultrasound and maternal biochemical markers at 32–36 weeks provides a poor prediction of APO in the general population. Although it remains limited, the performance of the screening model is improved when applied to fetuses with suboptimal fetal growth. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.